Papers
11
Total Citations
262
H-Index
8
About
Chen-Li Cheng is a pioneering urological surgeon and researcher whose work bridges robotic surgery, prostate cancer genomics, and precision oncology. His key research areas include robotic-assisted laparoscopic surgery, prostate cancer susceptibility, and the role of long noncoding RNA polymorphisms in cancer progression. Cheng’s most impactful contribution is his landmark study on the learning curve for robotic-assisted radical prostatectomy (RALP), which has garnered 116 citations and established critical benchmarks for reducing complications in single-surgeon series. He further advanced the field by documenting da Vinci system malfunctions and proposing solutions, a study cited 31 times. In genomics, Cheng identified that GAS5 and MALAT1 polymorphisms significantly influence prostate cancer risk and lymph node metastasis, with studies accumulating 27 and 15 citations, respectively. His work on carbonic anhydrase 9 expression provides a novel tool for predicting nodal metastasis in low-PSA patients. Notably, Cheng also demonstrated excellent long-term outcomes for robotic partial nephrectomy in renal angiomyolipoma and for RALP in Asian populations. With a career spanning over a decade at Taichung Veterans General Hospital, Cheng has shaped both surgical technique and molecular risk stratification, making him a leading figure in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2Malfunction of the da Vinci robotic system in urology31 citations · 2012
- 3
- 4Long-term outcome of robotic partial nephrectomy for renal angiomyolipoma17 citations · 2016
- 5
- 6
- 7
- 8
- 9
- 10